Refine search

Date
Tumour Site
Topics
Congress

249 results for ""

Vaccinate cancer patients against COVID-19: experts address major uncertainties

Vaccinate cancer patients against COVID-19: experts address major uncertainties

At an ESMO Live Roundtable, a panel of experts discussed the benefits and risk of COVID-19 vaccination in patients with cancer, the practicalities of vaccinating those undergoing immunosuppressant treatment and the potential advantages and disadvantages of flexible dosing intervals.

Telemedicine: the good and bad of living a hype

Telemedicine: the good and bad of living a hype

New forms of remote cancer care services have been piloted since the COVID-19 outbreak to offer support to patients while complying with hospital visiting restrictions. Despite a renewed popularity of telemedicine, digital services implemented so quickly may increase the risk of unmet expectations in the future.
Why we need to investigate sex differences in cancer research

Why we need to investigate sex differences in cancer research

Sex- and gender-sensitive medicine postulates that differences in biological sex, gender identity, role and relations all impact health and disease, and may have implications for prevention, screening, diagnosis and treatment. Its goal is to learn from these differences to improve care and treatment for men and women.

Finding ways to improve Academy-Industry collaboration

Finding ways to improve Academy-Industry collaboration

In cancer research, academy and industry still work in silos but there is room for improvement, and more successful partnership can rise from an in-depth acknowledgement of needs, shared area of interests and drivers for change. A very first step towards this direction has been taken by the Clinical Academic Cancer Research Forum (CAREFOR) – a multi-stakeholder platform aiming to improve academic cancer research in Europe – which conducted an analysis of current models, challenges and effective strategies for academic-industry research together with selected industry representatives.  The paper, which has been recently published on ESMO Open, (1) is a call to action to all oncology communities to join their efforts. Commenting on the paper, Professor Eric Van Cutsem from University of Leuven, Belgium, shares his perspectives on how investing in collaborative trials may be strategic for the benefit of patients.

Using the Microbiome to augment Immunotherapy response

Using the Microbiome to augment Immunotherapy response

The intriguing possibility that altering the microbiome might offer a way of augmenting response to immunotherapy is one of the pioneering new treatment options being explored in oncology.

TAT 2020 Honorary Award recipient Lillian L. Siu, Professor at the University of Toronto and Medical Oncologist at the Princess Margaret Cancer Centre, Toronto, explains the latest progress being made in using ‘bugs as drugs’.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.